157 related articles for article (PubMed ID: 17022778)
1. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study.
Louko AM; Vilkki J; Niskakangas T
Acta Neurol Scand; 2006 Nov; 114(5):315-9. PubMed ID: 17022778
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia.
Lanterna LA; Ruigrok Y; Alexander S; Tang J; Biroli F; Dunn LT; Poon WS
Neurology; 2007 Aug; 69(8):766-75. PubMed ID: 17709709
[TBL] [Abstract][Full Text] [Related]
3. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
4. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
5. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
[TBL] [Abstract][Full Text] [Related]
6. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
7. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
8. APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.
Lanterna LA; Rigoldi M; Tredici G; Biroli F; Cesana C; Gaini SM; Dalprà L
Neurology; 2005 Apr; 64(7):1238-44. PubMed ID: 15824354
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment and the role of the ApoE epsilon4-allele after stroke--a 13 months follow-up study.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Int J Geriatr Psychiatry; 2010 Aug; 25(8):833-42. PubMed ID: 19960482
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
11. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
12. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
Darreh-Shori T; Brimijoin S; Kadir A; Almkvist O; Nordberg A
Neurobiol Dis; 2006 Nov; 24(2):326-33. PubMed ID: 16973370
[TBL] [Abstract][Full Text] [Related]
13. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
14. Mortality in amnestic mild cognitive impairment: a prospective community study.
Hunderfund AL; Roberts RO; Slusser TC; Leibson CL; Geda YE; Ivnik RJ; Tangalos EG; Petersen RC
Neurology; 2006 Nov; 67(10):1764-8. PubMed ID: 17130407
[TBL] [Abstract][Full Text] [Related]
15. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR
Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739
[TBL] [Abstract][Full Text] [Related]
16. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
19. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
Klages J; Fisk JD
Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
[TBL] [Abstract][Full Text] [Related]
20. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
